Literature DB >> 28403020

Understanding the Impact of Preservation Methods on the Integrity and Functionality of Placental Allografts.

Amy Johnson1, Alexandra Gyurdieva, Sandeep Dhall, Alla Danilkovitch, Yi Duan-Arnold.   

Abstract

INTRODUCTION: Human placental membranes (hPMs) have a long history in treating burns and wounds. The composition of hPMs includes structural matrix, growth factors, and neonatal cells, all of which contribute to their regenerative potential. However, most hPM products are devitalized after dehydration and irradiation. We compared the functionality of single-layer viable cryopreserved human amniotic membrane (vCHAM) with multilayer devitalized dehydrated human amnion/chorion membrane (dHACM) in wound-relevant models to determine the effect of different processing methods on hPMs.
METHODS: Viable cryopreserved human amniotic membrane and dHACM were compared with fresh hPM for structural integrity and viability. Viable cell persistence in vCHAM over time was evaluated in vitro and in vivo in a diabetic chronic wound mouse model. Proliferation of cells within fresh hPM and vCHAM was evaluated with bromodeoxyuridine and Ki-67 staining, and proliferation of isolated cells in culture was evaluated. Growth factor release over time and in vitro response to chronic wound stimuli (tumor necrosis factor α, lipopolysaccharide, and hypoxia) were used to compare the functionality of vCHAM and dHACM.
RESULTS: The structure and thickness of fresh hPM were retained in vCHAM but were compromised in dHACM. Similar to fresh hPM, vCHAM contained viable cells, whereas dHACM did not. Cells in vCHAM remained viable after 4 and 7 days in culture and in an in vitro chronic wound environment and after 4 and 8 days in vivo after application to a mouse chronic wound. Staining for bromodeoxyuridine and Ki-67 did not reveal proliferative cells within fresh hPM and vCHAM. However, isolated cells proliferated in culture. Viable cryopreserved human amniotic membrane increased platelet-derived growth factor BB, hepatocyte growth factor, and epidermal growth factor levels over time and responded to chronic wound stimuli in vitro by significantly increasing levels of vascular endothelial growth factor and prostaglandin E2. Dehydrated human amnion/chorion membrane showed no significant accumulation of growth factors and did not respond to chronic wound stimuli.
CONCLUSIONS: These results indicate that vCHAM retains intact, native matrix, and viable, active cells and responds to chronic wound stimuli in vitro. The inclusion of multiple layers of hPM does not compensate for structural degradation and loss of viability caused by dehydration as evidenced by a lack of functional response by dHACM. The clinical significance of these results remains to be answered.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28403020     DOI: 10.1097/SAP.0000000000001101

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  17 in total

1.  The healing dynamics of non-healing wounds using cryo-preserved amniotic membrane.

Authors:  Alzbeta Svobodova; Vojtech Horvath; Ingrida Smeringaiova; Joao Victor Cabral; Martina Zemlickova; Radovan Fiala; Jan Burkert; Denisa Nemetova; Petr Stadler; Jaroslav Lindner; Jan Bednar; Katerina Jirsova
Journal:  Int Wound J       Date:  2021-11-17       Impact factor: 3.099

2.  Use of Viable Cryopreserved Placental Membrane as an Adjunct to Facial Keloid Resection.

Authors:  Rishi J Gupta; Stephen T Connelly; Rebeka G Silva; Nat R Gwilliam
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-01-11

3.  Meshed Split-Thickness Autograft With a Viable Cryopreserved Placental Membrane Overlay for Lower-Extremity Recipient Sites With Increased Risk of Graft Failure.

Authors:  Michael A Lavor; Georgina M Michael; Yeabsera G Tamire; Nicole D Dorofee
Journal:  Eplasty       Date:  2018-07-05

4.  Letter to the Editor.

Authors:  Donald Fetterolf; Thomas Koob
Journal:  Ann Plast Surg       Date:  2017-11       Impact factor: 1.539

5.  Viable cryopreserved umbilical tissue (vCUT) reduces post-operative adhesions in a rabbit abdominal adhesion model.

Authors:  Sandeep Dhall; Turhan Coksaygan; Tyler Hoffman; Matthew Moorman; Anne Lerch; Jin-Qiang Kuang; Malathi Sathyamoorthy; Alla Danilkovitch
Journal:  Bioact Mater       Date:  2018-10-10

6.  Antimicrobial Peptides Secreted From Human Cryopreserved Viable Amniotic Membrane Contribute to its Antibacterial Activity.

Authors:  Yong Mao; Tyler Hoffman; Anya Singh-Varma; Yi Duan-Arnold; Matthew Moorman; Alla Danilkovitch; Joachim Kohn
Journal:  Sci Rep       Date:  2017-10-20       Impact factor: 4.379

7.  A case of Dupuytren's disease managed with viable cryopreserved placental membrane adjunct to open palmar fasciectomy.

Authors:  Christopher M Dress; Elisabet K Tassis
Journal:  J Surg Case Rep       Date:  2018-03-31

8.  A Flowable Placental Formulation Prevents Bleomycin-Induced Dermal Fibrosis in Aged Mice.

Authors:  Sandeep Dhall; Anne Lerch; Nicholas Johnson; Vimal Jacob; Brielle Jones; Min Sung Park; Malathi Sathyamoorthy
Journal:  Int J Mol Sci       Date:  2020-06-14       Impact factor: 5.923

9.  Properties of viable lyopreserved amnion are equivalent to viable cryopreserved amnion with the convenience of ambient storage.

Authors:  Sandeep Dhall; Malathi Sathyamoorthy; Jin-Qiang Kuang; Tyler Hoffman; Matthew Moorman; Anne Lerch; Vimal Jacob; Steven Michael Sinclair; Alla Danilkovitch
Journal:  PLoS One       Date:  2018-10-02       Impact factor: 3.240

10.  Nonsurgical management of a large necrotic nasal tip wound using a viable cryopreserved placental membrane.

Authors:  Eric L Johnson; Alla Danilkovitch
Journal:  Clin Case Rep       Date:  2018-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.